Sep 27, 2023

Wave of medical imaging innovation hits shores of Lake Superior

Sep 19, 2023

Ask a Cancer Researcher: How does blood change as we age?

Sep 14, 2023

New OICR investigator combines physics, chemistry, and artificial intelligence to improve tissue imaging

Aug 31, 2023

New member of executive team will strengthen OICR’s commitment to patients, equity and impact

Aug 29, 2023

The Next Generation: Jingping Qiao

Aug 29, 2023

Ask a Cancer Researcher: How can we predict if breast cancer will come back?

Aug 16, 2023

New network to give improved options to Ontarians with hereditary cancers

Aug 16, 2023

Student researcher collaborating with Indigenous community to improve cancer screening

Aug 15, 2023

CanPath partnership sheds light on COVID-19 immunity across Canada

Aug 11, 2023

The secret to stopping deadly cancer recurrences may be in your blood

Jul 27, 2023

The Next Generation: Tom Ouellette

Jul 25, 2023

OICR introduces groundbreaking test proven to find traces of cancer in blood

Jul 19, 2023

Ask a Cancer Researcher: What happens to samples donated to tumour banks?

Jul 17, 2023

The ‘incredible’ way the HPV virus causes cancer and what that means for treating it

Jul 12, 2023

Paying it forward with a patient perspective

Jul 07, 2023

Fecal transplants bolster melanoma treatment in unique clinical trial

Jun 29, 2023

New framework aims to drive innovation by making health data management ‘FAIR’

Jun 28, 2023

The Next Generation: Aisha Naamani

Jun 26, 2023

Why some patients with a rare but deadly leukemia fare much better than others

Jun 21, 2023

Ask a Cancer Researcher: What is immunotherapy?

Jun 20, 2023

New funding partnership with U of T Data Sciences Institute aims to drive new breakthroughs

Jun 14, 2023

Cancer researchers focused on bringing new discoveries to patients get two-year funding awards

Jun 07, 2023

Patient partner driven to make cancer care more inclusive

Jun 07, 2023

How Falcons’ Fortunes winner plans to stop colorectal cancer from coming back

May 17, 2023

The Next Generation: Alister D’Costa

May 11, 2023

Ask a Cancer Researcher: What happens after a new discovery?

May 09, 2023

CanPath transforming data access to unlock its full potential to improve health

May 09, 2023

Precision magnetics could be game-changer for therapy-resistant brain cancers

May 04, 2023

Investment in Ontario drug discovery research will help develop new cancer medicines for patients

Apr 26, 2023

Ask a Cancer Researcher: Why do we sequence tumour DNA?

Apr 24, 2023

The Next Generation: Xindi Zhang

Apr 17, 2023

Join the OICR Board

Apr 05, 2023

OICR-led teams receive historic multimillion dollar funding to tackle hard-to-treat cancers

Apr 04, 2023

New Associate Director says Ontario Tumour Bank can be ‘bridge’ to future cancer innovations

Apr 04, 2023

Third major accreditation to help OICR Genomics power next generation of precision medicine

Apr 03, 2023

‘Upswing’ in patient partnership presents opportunities for impact, says new PFAC chair

Mar 14, 2023

The Next Generation: Hector Gonzalez Alvarez

Mar 08, 2023

International Women's Day: How can we build momentum for women in STEM?

Feb 10, 2023

The Next Generation: Kimberly Skead

Feb 02, 2023

OICR researchers join Lancet commission to tackle inequities in precision cancer care

Jan 31, 2023

How research is helping “close the care gap” in cancer

Jan 18, 2023

Pioneer in primary care oncology named to Order of Canada

Jan 17, 2023

The Next Generation: Andy Zeng

Jan 12, 2023

Low-cost molecular test targets more efficient brain cancer diagnosis

Jan 12, 2023

Drug Discovery scientist wants to speed up development of new cancer therapeutics

Dec 15, 2022

The Next Generation: Ido Nofech-Mozes

Dec 15, 2022

OICR-led data resource deemed ‘critical’ to global biomedical research

Dec 15, 2022

New directors of OICR Diagnostic Development program set sights on bringing discoveries to the clinic

Dec 14, 2022

Can tumours shrink with a placebo alone?

Dec 08, 2022

Zooming in on mouse brain development reveals origins of human glial cancers

Dec 06, 2022

‘Seemingly inconsequential’ inherited DNA mutation triggers sixfold increase in brain tumour risk

Nov 30, 2022

Cancer research community loses a pillar of patient partnership in Jill Hamer-Wilson

Nov 24, 2022

Navigating hope: Helping cancer patients find and enrol in clinical trials

Nov 23, 2022

The Next Generation: Nick Cheng is looking for early signs of cancer

Nov 22, 2022

Breaking through the blood-tumour barrier to better treat brain cancer

Nov 17, 2022

How patients can improve the way new cancer therapies are assessed

Nov 15, 2022

Three OICR scientists make ‘highly cited researchers’ list

Nov 01, 2022

OICR welcomes four new Board members

Oct 26, 2022

The Next Generation: Michelle Harwood, OICR-based PhD candidate, studying what genetic variance means for aging and disease

Oct 26, 2022

AI-generated software spots skin cancer with accuracy and efficiency

Oct 18, 2022

Promising virtual platform connects primary care providers with geneticists

Oct 05, 2022

Patient perspectives fuelling translational OICR studies

Sep 27, 2022

The Next Generation: Mahmoud Noureldin

Sep 15, 2022

OICR Impact Report

Sep 14, 2022

New CPDC spinout company aims to become global leader in developing and distributing radiopharmaceuticals

Aug 29, 2022

Previously overlooked proteins are a potential source for a new class of cancer killing drugs

Aug 24, 2022

Prostate cancer trial aims to deliver shorter, more effective radiotherapy thanks to advanced imaging

Aug 15, 2022

Trusting the gut in cancer research: Q&A with Dr. Saman Maleki

Aug 11, 2022

Funding from Ontario Institute for Cancer Research to help move research from experiment to impact

Aug 08, 2022

FACIT pitch competition empowers Ontario’s oncology entrepreneurs

Aug 02, 2022

Making liver cancer ablations more accurate with 3D ultrasound guidance

Jul 20, 2022

How natural selection influences gene expression and can protect us from disease

Jul 11, 2022

Genome sequencing delivers real-time results for hard-to-treat pancreatic cancer

Jul 05, 2022

New precision diagnostics predict risk and response to breast cancer therapies

Jun 24, 2022

Leveraging Big Data to drive cancer innovations

Jun 16, 2022

Join the OICR Board

Jun 16, 2022

OICR announces funding for three new window-of-opportunity clinical trials

Jun 01, 2022

New ICGC DACO website offers improved access to cancer data

May 18, 2022

OICR launches new Patient Partnership Plan

May 11, 2022

Innovative MRI shines new light on cancer

May 10, 2022

New research asks if clinical trials are losing sight of what matters most to cancer patients

May 02, 2022

Building evidence for the landmark U.S. ban on menthol cigarettes

Apr 28, 2022

Predicting cancer evolution with deep learning algorithms

Apr 28, 2022

Two OICR innovations bolstered by investments from FACIT

Apr 25, 2022

Adding another dimension to breast cancer screening

Apr 20, 2022

Up-and-coming research trainees receive OICR Rising Stars awards

Apr 13, 2022

Award-winning co-op student makes her mark on pancreatic cancer research

Apr 07, 2022

OICR Genomics earns internationally recognized accreditation

Apr 06, 2022

New Chair of patient advisory council taking OICR patient partnership into next phase

Mar 30, 2022

Mammography innovator changing how we see cancer

Mar 07, 2022

New gene signature test predicts risk of acute myeloid leukemia relapse

Mar 04, 2022

Made-in-Canada CAR-T cells save lives in promising clinical trial

Feb 24, 2022

Cancer researcher leads push to elevate Black scientists

Feb 10, 2022

FACIT award winners to give surgeons 10-second solution to identify cancer

Feb 08, 2022

Data from 10,000 Ontario Health Study participants studied for vaccine effectiveness

Jan 24, 2022

Radiation or surgery: finding the best treatment for oropharyngeal cancer

Jan 14, 2022

Ontario’s support for research will change lives across the province

Jan 05, 2022

Proactive outreach program helps chemotherapy patients manage side effects

Jan 04, 2022

Dr. Geoffrey Fong appointed Officer of the Order of Canada

Dec 15, 2021

Mapping the Canadian clinical trials landscape in precision oncology to identify trial opportunities for patients, clinicians and researchers

Dec 02, 2021

Ontario Institute for Cancer Research announces funding for sixteen studies that support early detection of cancer, the development of new diagnostics to guide therapy and improved treatment options for patients

Dec 01, 2021

New funding from the Ontario Institute for Cancer Research supports projects developing methods for cancer detection and tools to facilitate better treatment decisions for high-risk cancer patients

Nov 23, 2021

International Cancer Genome Consortium empowers cancer researchers everywhere with new cloud computing platform

Nov 18, 2021

Susan Fitzpatrick named Chair of OICR’s Board of Directors

Nov 17, 2021

Changes to executive team will make OICR stronger and more responsive to the needs of the Ontario cancer research community

Nov 15, 2021

New prognostic biomarkers and cancer-driving genes found in the dark matter of the cancer genome

Oct 08, 2021

Study puts spotlight on FDA’s accelerated approval of cancer drugs

Oct 04, 2021

New AI tool enables analysis of millions of cells within minutes

Sep 26, 2021

We’re pleased to announce the next JLABS seminar will be held on November 17

Sep 07, 2021

Clinical trial breaks new ground on using immunotherapy for more cancer types

Aug 17, 2021

Researchers uncover evolutionary forces at play in the aging of the blood system and identify people at increased risk of blood cancer

Aug 13, 2021

Largest study of its kind informs treatment of breast cancer in men

Jul 13, 2021

Microscopes and molecules: New OICR Investigator Dr. Rola Saleeb brings integrated approach to cancer pathology

Jul 06, 2021

Learning how to fly blind

Jun 11, 2021

Unravelling the secrets of the non-coding cancer genome